arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

AVENUE THERAPEUTICS, INC.

ATXI

— Price unavailable

12 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

AVENUE THERAPEUTICS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin -219.6%

ROIC -132.9% ↗

FCF / Share $-0.59 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

12-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.40M

— —

Net Income Profit after all expenses

$-2.91M

↑ +75.0% —

FCF / Share Free cash flow per share

$-0.59

↑ +91.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Feb 8, 2015 10-K ↗
EPS Growth YoY (%)	94.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	78.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-337998.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-11013.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	29.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	75.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-11.1% Weak ↑ Weak Improving Year-over-year change in net income	-191.1% Weak ↓ Weak Declining Year-over-year change in net income	3.4% Caution ↓ Caution Declining Year-over-year change in net income	27.6% Excellent ↑ Excellent Improving Year-over-year change in net income	80.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-20.2% Weak ↑ Weak Improving Year-over-year change in net income	-75.8% Weak ↑ Weak Improving Year-over-year change in net income	-285.8% Weak Weak Year-over-year change in net income	39.2% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	91.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	89.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-144289.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	-23534.6% Weak Weak Year-over-year change in free cash flow	21.1% Good Good Year-over-year change in free cash flow	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Feb 8, 2015 10-K ↗
Operating Margin (%) (%)	-219.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1564%)	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-207.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1827%)	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-130.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.63x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	2.11x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.17x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Feb 8, 2015 10-K ↗
Return on Invested Capital (%)	-132.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-318.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-726.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-162.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-85.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-174.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-305.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2731.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-46.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	22.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	74.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-105.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-422.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-785.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-117.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-94.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-160.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-294.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-482.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-51.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-1206.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-158.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1159%)	—	—	-92.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-715%)	-108.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-821%)	-218.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1556%)	—	—	-63.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-522%)	38.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+157%)	101.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+578%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Feb 8, 2015 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	-38.85x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5.66x Weak Weak Operating income divided by interest expense Optimal: > 5x	-22.53x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-2.85M	$-2.59M	$-1.78M	$-6.71M	$-3.76M	$-3.13M	$-8.74M	$-2.67M	$-11.78M	$-197.00K	$-14.00K	$0.00

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Feb 8, 2015 10-K ↗
Revenue per Share (USD)	$0.45	$0.00	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.93	$-15.79	$-73.48	$-0.02	$-0.00	$-0.00	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.59	$-6.97	$-66.92	$-0.05	$-0.00	$-0.00	—	—	—	—	—	—
Book Value per Share (USD)	$0.58	$1.33	$4.63	$0.01	$0.00	$0.00	$0.00	$-0.00	$0.00	$-0.00	—	—
Tangible Book Value per Share (USD)	$0.58	$1.33	$4.63	$0.01	$0.00	$0.00	$0.00	$-0.00	$0.00	$-0.00	—	—
Basic Weighted Avg Shares (shares)	3.13M	1.30M	141,222	163.89M	19.12B	18.57B	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Feb 8, 2015 10-K ↗
Working Capital (USD)	—	—	—	—	$3.45M	$2.36M	—	—	—	—	—	—
Total Equity (USD)	$1.83M	$2.80M	$1.58M	$3.90M	$3.45M	$2.36M	$6.80M	$-631.00K	$19.38M	$-8.25M	$-5.13M	$0.00

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Feb 8, 2015 10-K ↗
Sales/Revenue/Turnover (USD)	$1.40M	$0.00	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-2.91M	$-11.65M	$-10.49M	$-3.60M	$-3.73M	$-5.15M	$-25.91M	$-21.55M	$-12.26M	$-3.18M	$-5.23M	—
Operating Cash Flow (USD)	$-1.83M	$-9.03M	$-9.45M	$-7.60M	$-3.75M	$-4.61M	$-26.26M	$-18.22M	$-6.80M	$-1.63M	$-895.00K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 12 years · 43 quarters

AVENUE THERAPEUTICS, INC.

Analytical Summary

12-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ATXI with peers